Skip to main content

Table 2 Number and mortality rate of bladder cancer, kidney cancer and prostate cancer by sex and age at 1990, 2019 and projected 2030

From: Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030

 

Number of deaths (95% UI) (per 1000)

Mortality rate (95% UI) (per 100,000)

EAPC (95% CI)

1990

2019

2030

1990

2019

2030

1990 ~ 2019

2020 ~ 2030

Prostate

Male a

20·38(15·08,25·72)

54·39(41·82,72·32)

81·54(61·83,101·25)

7·96(6·03,10·36)

8·09(6·23,10·57)

7·69(5·83,9·56)

0·11(0·04,0·18)

-0·29(-0·31,-0·27)

Age group

        

0 ~ 19 b

-

-

-

-

-

-

-

-

20 ~ 39 b

0·16(0·11,0·20)

0·14(0·11,0·19)

0·11(0·05,0·17)

0·08(0·05,0·09)

0·07(0·05,0·09)

0·06(0·03,0·09)

-0·88(-1·14,-0·62)

-0·68(-1·01,-0·35)

40 ~ 59 b

1·56(1·04,2·00)

2·50(1·81,3·54)

2·57(1·91,3·23)

1·49(0·99,1·91)

1·13(0·82,1·59)

1·15(0·86,1·45)

-1·11(-1·25,-0·97)

-0·42(-1·14,0·30)

60 ~ 79 b

13·51(9·89,16·59)

29·83(22·77,40·94)

45·32(34·41,56·23)

29·51(21·59,36·22)

28·15(21·49,38·63)

28·92(21·96,35·89)

-0·23(-0·45,-0·01)

0·15(0·02,0·29)

80 ~ b

5·15(4·04,6·94)

21·91(17·12,27·65)

33·54(25·47,41·62)

191·55(150·39,258·18)

215·15(168·14,271·47)

205·37(155·92,254·83)

0·70(0·47,0·94)

0·09(0·06,0·13)

Bladder

Total a

17·29(14·81,19·85)

40·09(33·55,47·67)

61·22(43·37,79·09)

2·65(2·27,3·04)

2·49(2·09,2·94)

2·49(1·76,3·21)

-0·13(-0·20,-0·06)

0·00(-0·02,0·03)

Male a

11·91(9·81,14·09)

31·50(25·37,38·53)

47·53(34·02,61·03)

4·30(3·57,5·05)

4·43(3·62,5·35)

4·37(3·13,5·62)

0·22(0·12,0·32)

0·00(-0·01,0·02)

Female a

5·38(4·37,6·57)

8·59(6·74,10·62)

13·42(7·92,18·92)

1·53(1·25,1·86)

0·99(0·78,1·22)

1·00(0·59,1·41)

-1·53(-1·62,-1·44)

0·07(0·05,0·09)

Age group

-

-

-

-

-

-

-

-

0 ~ 19 b

0·05(0·04,0·06)

0·01(0·01,0·02)

0·01(0·00,0·03)

0·04(0·04,0·05)

0·02(0·01,0·02)

0·01(0·00,0·03)

-3·75(-4·03,-3·47)

-0·72(-0·93,-0·52)

20 ~ 39 b

0·67(0·56,0·78)

0·46(0·38,0·55)

0·27(0·16,0·38)

0·16(0·14,0·19)

0·11(0·09,0·13)

0·08(0·04,0·11)

-1·95(-2·23,-1·68)

-2·11(-2·69,-1·52)

40 ~ 59 b

3·04(2·55,3·56)

4·66(3·74,5·78)

4·18(2·94,5·43)

1·52(1·27,1·77)

1·07(0·86,1·32)

0·96(0·67,1·25)

-1·15(-1·29,-1·01)

-1·43(-1·94,-0·92)

60 ~ 79 b

9·88(8·51,11·31)

21·20(17·60,25·50)

34·11(24·21,44·01)

10·68(9·20,12·23)

9·79(8·13,11·78)

10·58(7·51,13·66)

-0·29(-0·53,-0·05)

0·48(0·28,0·68)

80 ~ b

3·65(3·15,4·14)

13·77(11·81,15·83)

22·65(16·07,29·24)

48·75(42·02,55·32)

53·73(46·10,61·78)

54·91(38·95,70·88)

0·62(0·36,0·87)

0·54(0·48,0·60)

Kidney

Total a

5·88(4·94,6·91)

23·95(19·64,28·82)

41·94(0·00,91·21)

0·70(0·59,0·81)

1·34(1·10,1·60)

1·84(0·00,4·03)

3·06(2·62,3·50)

3·45(3·22,3·67)

Male a

3·33(2·61,4·18)

16·88(12·99,21·23)

31·67(0·00,74·43)

0·82(0·65,1·01)

1·98(1·54,2·47)

2·90(0·00,6·84)

4·06(3·57,4·56)

3·97(3·70,4·25)

Female a

2·55(2·07,3·08)

7·07(5·54,8·81)

10·93(0·92,21·06)

0·60(0·49,0·72)

0·77(0·60,0·96)

0·93(0·07,1·83)

1·35(1·01,1·70)

2·23(2·09,2·36)

Age group

        

0 ~ 19 b

0·62(0·51,0·75)

0·37(0·30,0·44)

0·31(0·00,0·92)

0·14(0·11,0·16)

0·11(0·09,0·13)

0·11(0·00,0·32)

-0·29(-0·62,0·03)

0·44(-0·40,1·30)

20 ~ 39 b

0·61(0·50,0·72)

1·59(1·29,1·94)

1·95(0·00,4·24)

0·15(0·12,0·17)

0·38(0·31,0·46)

0·56(0·00,1·22)

4·35(3·70,5·01)

3·95(3·74,4·15)

40 ~ 59 b

2·06(1·71,2·47)

8·28(6·55,10·27)

14·74(0·00,31·97)

1·03(0·85,1·23)

1·90(1·50,2·35)

3·38(0·00,7·33)

2·97(2·59,3·36)

4·60(4·50,4·71)

60 ~ 79 b

2·08(1·79,2·39)

9·32(7·78,11·04)

18·02(0·00,39·08)

2·25(1·94,2·59)

4·30(3·59,5·10)

5·59(0·00,12·12)

2·74(2·17,3·32)

2·66(2·40,2·92)

80 ~ b

0·50(0·43,0·57)

4·40(3·71,5·14)

6·92(0·00,15·01)

6·74(5·75,7·64)

17·19(14·50,20·05)

16·77(0·00,36·39)

4·59(4·00,5·18)

1·95(1·85,2·06)

  1. EAPC estimated annual percentage change, 95% UI 95% uncertainty interval, 95% CI 95% confidence interval
  2. a age-standardized mortality rate
  3. b crude incidence rate in each age group